Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Non-cash Items (2016 - 2018)

Sangamo Therapeutics (SGMO) has 7 years of Non-cash Items data on record, last reported at $24.5 million in Q4 2018.

  • For Q4 2018, Non-cash Items rose 530.44% year-over-year to $24.5 million; the TTM value through Dec 2018 reached $24.5 million, up 530.44%, while the annual FY2018 figure was $24.5 million, 530.44% up from the prior year.
  • Non-cash Items reached $24.5 million in Q4 2018 per SGMO's latest filing, up from $3.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $24.5 million in Q4 2018 and bottomed at $3.9 million in Q4 2017.
  • Average Non-cash Items over 5 years is $8.9 million, with a median of $5.0 million recorded in 2015.
  • Peak YoY movement for Non-cash Items: tumbled 35.69% in 2017, then skyrocketed 530.44% in 2018.
  • A 5-year view of Non-cash Items shows it stood at $4.9 million in 2014, then grew by 0.42% to $5.0 million in 2015, then increased by 21.89% to $6.0 million in 2016, then crashed by 35.69% to $3.9 million in 2017, then surged by 530.44% to $24.5 million in 2018.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $24.5 million in Q4 2018, $3.9 million in Q4 2017, and $6.0 million in Q4 2016.